(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.23%) $79.18
(0.83%) $1.948
(0.94%) $2 332.70
(0.87%) $26.98
(1.38%) $968.10
(0.01%) $0.933
(-0.02%) $11.03
(-0.04%) $0.798
(0.27%) $93.51
7.29% $ 11.77
@ $12.36
Emitido: 14 feb 2024 @ 09:30
Retorno: -4.77%
Señal anterior: feb 12 - 15:00
Señal anterior:
Retorno: -1.98 %
Live Chart Being Loaded With Signals
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation...
Stats | |
---|---|
Volumen de hoy | 269 443 |
Volumen promedio | 192 104 |
Capitalización de mercado | 378.64M |
EPS | $0 ( 2024-04-25 ) |
Próxima fecha de ganancias | ( $0.0300 ) 2024-05-16 |
Last Dividend | $0.100 ( 2022-01-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 43.59 |
ATR14 | $0.0260 (0.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | Lucsok Anna | Buy | 1 025 | Common Stock (Restricted Stock Award) |
2024-04-27 | Lucsok Anna | Buy | 5 000 | Common Stock (Restricted Stock Award) |
2024-04-29 | Lucsok Anna | Sell | 2 395 | Common Stock |
2024-03-25 | Moorhead Daniel J | Sell | 6 084 | Common Stock |
2024-03-25 | Lucsok Anna | Sell | 7 672 | Common Stock |
INSIDER POWER |
---|
-36.67 |
Last 100 transactions |
Buy: 371 745 | Sell: 901 167 |
Volumen Correlación
Zynex Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
MMAC | 0.896 |
BOCH | 0.863 |
BMRN | 0.848 |
CTRN | 0.841 |
STRO | 0.838 |
XEL | 0.832 |
CAAS | 0.826 |
ISRG | 0.821 |
AMRB | 0.814 |
GLSI | 0.812 |
10 Correlaciones Más Negativas | |
---|---|
APOP | -0.971 |
RMRM | -0.939 |
MAGS | -0.936 |
TDAC | -0.897 |
CMLF | -0.868 |
SVOK | -0.836 |
EMBCV | -0.824 |
TLGT | -0.823 |
SPRT | -0.82 |
TALS | -0.82 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Zynex Inc Correlación - Moneda/Commodity
Zynex Inc Finanzas
Annual | 2023 |
Ingresos: | $184.32M |
Beneficio Bruto: | $145.96M (79.19 %) |
EPS: | $0.270 |
FY | 2023 |
Ingresos: | $184.32M |
Beneficio Bruto: | $145.96M (79.19 %) |
EPS: | $0.270 |
FY | 2022 |
Ingresos: | $158.17M |
Beneficio Bruto: | $126.16M (79.77 %) |
EPS: | $0.440 |
FY | 2021 |
Ingresos: | $130.30M |
Beneficio Bruto: | $102.98M (79.03 %) |
EPS: | $0.450 |
Financial Reports:
No articles found.
Zynex Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.136 | 2014-06-17 |
Last Dividend | $0.100 | 2022-01-05 |
Next Dividend | $0 | N/A |
Payout Date | 2022-01-21 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.300 | -- |
Avg. Dividend % Per Year | 0.21% | -- |
Score | 2.67 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.49 | |
Div. Directional Score | 7.84 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0.136 | 42.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0.0636 | 2.14% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0.100 | 1.07% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0528 | 1.500 | 8.94 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0690 | 1.200 | 7.70 | 9.24 | [0 - 0.3] |
returnOnEquityTTM | 0.168 | 1.500 | 9.24 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.000308 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 4.74 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.85 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.41 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.436 | -1.500 | 2.73 | -4.10 | [0 - 0.6] |
interestCoverageTTM | 11.13 | 1.000 | 6.99 | 6.99 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.531 | 2.00 | 9.82 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.495 | 2.00 | 9.75 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.334 | -1.500 | 4.66 | -7.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.792 | 1.000 | 0.136 | 0.136 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0661 | 1.000 | -0.678 | -0.678 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.290 | 1.000 | 9.50 | 9.50 | [0.2 - 2] |
assetTurnoverTTM | 1.307 | 0.800 | 4.62 | 3.70 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 37.87 | 1.000 | 6.28 | 0 | [1 - 100] |
returnOnEquityTTM | 0.168 | 2.50 | 9.51 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.495 | 2.00 | 9.84 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.531 | 2.00 | 9.82 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.000308 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0.370 | 1.500 | -0.867 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0967 | 1.000 | -0.0814 | 0 | [0.1 - 0.5] |
Total Score | 4.49 |
Zynex Inc
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico